menu
    • menu
    [{"orgOrder":0,"company":"NOVOS","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"U.S.A","productType":"Carbohydrate","year":"2024","type":"Inapplicable","leadProduct":"Trehalose","moa":"||TFEB","graph1":"Cardiology\/Vascular Diseases","graph2":"Approved FDF","graph3":"NOVOS","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Gum, Chewing","sponsorNew":"NOVOS \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"NOVOS \/ Undisclosed"},{"orgOrder":0,"company":"NOVOS","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"U.S.A","productType":"Vaccine","year":"2014","type":"Inapplicable","leadProduct":"Hepatitis B (Recombinant) Vaccine","moa":"HBsAg||Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase I","graph3":"NOVOS","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Injection","sponsorNew":"NOVOS \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"NOVOS \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals by NOVOS

    Menu

    NOVOS

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            NOVOS

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            NOVOS

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Trehalose,Nattokinase,Rutin

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            NOVOS Launches Daily Chew to Optimize and Maintain Essential Organ Function

                            Details : Novos vital is a groundbreaking supplement chew scientifically formulated with an ingredient blend shown to support and optimize essential organ functions that decline with age.

                            Product Name : Novos Vital

                            Product Type : Carbohydrate

                            Upfront Cash : Inapplicable

                            February 21, 2024

                            Lead Product(s) : Trehalose,Nattokinase,Rutin

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            NOVOS

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            NOVOS

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Hepatitis B Vaccine (Recombinant Dna),Hepatitis B (Recombinant) Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase I

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID

                            Details : HBVaxPro (Hepatitis B Vaccine (Recombinant Dna)) is a Vaccine drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Hepatitis B.

                            Product Name : HBVaxPro

                            Product Type : Vaccine

                            Upfront Cash : Inapplicable

                            July 10, 2014

                            Lead Product(s) : Hepatitis B Vaccine (Recombinant Dna),Hepatitis B (Recombinant) Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase I

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth